Business, energy, technology, markets and global industry news from Business News Today

Saarlouis

PharmaDeviceNews Saarlouis
Representative image: Vetter’s Saarlouis expansion highlights the rising demand for sterile injectable drug manufacturing capacity in Europe as pharma companies seek scalable, high-quality fill-finish infrastructure for complex medicines.
Pharma & Biotech

Why Vetter’s Saarlouis expansion matters for sterile injectable supply chains

Injectable capacity is tightening. Vetter’s Saarlouis bet shows why Europe wants more control over sterile drug manufacturing.

Read More
Representative image of a CDMO-led aseptic drug manufacturing facility in Europe, illustrating how state-aided projects like Vetter Pharma’s Saarlouis plant are reshaping pharmaceutical supply chains in post-industrial regions.
Features & Analysis

Can EU-backed CDMO projects redefine pharma supply chains in post-industrial Europe?

The European Commission’s recent approval of €47 million in German state aid for Vetter Pharma’s new aseptic filling facility in Saarlouis marks more than a regional win. It signals a structural shift in how Europe views contract manufacturing organizations, or CDMOs—not merely as outsourcing vendors, but as core pillars of supply chain resilience, regional economic

Read More